At a glance
- Medvi is a LegitScript-certified GLP-1 telehealth clinic, not a research-peptide vendor.
- Trustpilot rating: 4.4 out of 5 across more than 12,000 reviews as of 2026.
- Compounded semaglutide starts at $179 the first month; compounded tirzepatide runs up to $399.
- It prescribes compounded semaglutide and tirzepatide plus brand Wegovy and Zepbound. No insurance.
- Compounded GLP-1s are not FDA-approved and vary in quality, which is the main caveat to weigh.
Medvi has more than 12,000 Trustpilot reviews and a 4.4-star average. That is a lot of receipts for a GLP-1 clinic most people first hear about from an ad. The question underneath the star rating is simpler: is the medication real, is the price honest, and what is the catch. Here is what the reviews, the pricing, and the fine print actually say.
What Medvi is, and what it is not
Medvi is a telehealth weight-loss clinic. You fill out an online health questionnaire, a licensed provider reviews it, and if you qualify, a GLP-1 prescription ships to your door. It is not a research-peptide vendor like the ones we cover in the lab-tests library, and it is not a pharmacy you walk into. It sits in the same category as the telehealth programs in our GLP-1 hub.
The medications: Medvi prescribes compounded semaglutide and compounded tirzepatide (both as weekly injections and daily oral dissolving tablets), plus the brand drugs Wegovy and Zepbound. If you want the dosing detail on those, see the Wegovy dosage chart and the Zepbound dosage chart.
How it works
The flow is standard for the category: a 10 to 15 minute intake questionnaire, provider review usually within 24 hours, then free expedited shipping that typically lands within a few days of approval. No in-person visit, no lab draw for most applicants, and no insurance. You pay cash, though HSA and FSA cards are accepted.
What Medvi costs
Pricing is flat-rate and rises after the first month, which is the part the intro-price ads tend to bury.
| Medication | First month | Ongoing |
|---|---|---|
| Compounded semaglutide (injection) | $179 | up to $299 |
| Compounded semaglutide (oral tablets) | $249 | up to $369 |
| Compounded tirzepatide (injection or tablets) | $279 | up to $399 |
Note: The first-month price is a promotion. Budget for the ongoing number, because GLP-1 therapy is a months-long commitment, not a one-month trial.
Is Medvi legit?
On the trust signals that matter, Medvi checks out. It is LegitScript certified, which means an independent body monitors it for legal compliance and transparency. Its Trustpilot profile sits at 4.4 out of 5 across 12,000-plus reviews, and mainstream outlets like U.S. News and ConsumerAffairs list it as a real, operating clinic with a money-back guarantee.
The complaints are consistent and worth knowing before you sign up: billing surprises (the intro-to-ongoing price jump), occasional shipping delays, and the friction of cancelling. These are operational gripes, not "the medication was fake" gripes, which is the more reassuring kind of complaint pattern.
The compounded-GLP-1 caveat
Here is the real asterisk. Most of Medvi's volume is compounded semaglutide and tirzepatide, and compounded drugs are not FDA-approved. They can differ in formulation, concentration, and quality from the brand versions. That is not a Medvi-specific problem, it is a category problem: an analysis of no-prescription semaglutide found products testing far below their labeled purity with endotoxin in every sample (JMIR 2024). Medvi's compounding is done through licensed pharmacies, which is a meaningfully higher bar than a gray-market vial, but "compounded" still means "not the FDA-approved product." If that matters to you, the brand Wegovy and Zepbound options exist for a higher price.
The underlying drugs work. Semaglutide produced about 15% mean weight loss in the STEP-1 trial (Wilding et al. 2021), and tirzepatide reached 16% to 22.5% in SURMOUNT-1 (Jastreboff et al. 2022). The efficacy question is settled. The open questions with any telehealth compounder are quality control and price transparency.
Who it is for
Medvi fits someone who wants a low-friction, cash-pay GLP-1 program and is comfortable with compounded medication. If you specifically want brand-name Wegovy or Zepbound, or you want to compare the cash price against other clinics, our cheapest GLP-1 options and compounded tirzepatide and compounded semaglutide pages line up the alternatives.
Bottom line: Medvi is a legitimate, LegitScript-certified GLP-1 telehealth clinic with strong Trustpilot numbers and real medication. The two things to weigh are the first-month-to-ongoing price jump and the compounded-versus-brand tradeoff. Compare it against the clinician-managed programs in our GLP-1 hub before committing.
This article is for educational purposes only and is not medical advice. GLP-1 medications are prescription drugs that require evaluation by a licensed clinician. Compounded medications are not FDA-approved. We may earn a commission on telehealth programs referred from this site; our assessment would be the same without it.
